Table 1.
Baseline characteristics of HGG patients
| Characteristic | No. (%) |
|---|---|
| Gender | |
| Male | 16 (53.3) |
| Female | 14 (46.7) |
| Age (years) | |
| ≤ 60 | 24 (80) |
| > 60 | 6 (20) |
| Preoperative KPS | |
| 80–90 | 8 (26.7) |
| ≥ 90 | 22 (73.3) |
| Pathologic grade | |
| Grade III | 17 (56.7) |
| Grade IV | 13 (43.3) |
| Tumor volume (cm3) | |
| Median (IQR) | 20.04 (10.68–42.92) |
| Range | 1.83–80.66 |
| PTBE volume (cm3) | |
| Median (IQR) | 105.26 (56.92–137.37) |
| Range | 17.2–235.65 |
| Tumor location | |
| Type I | 11 (36.7) |
| Type II | 9 (30) |
| Type III | 10 (33.3) |
| Molecular markers | |
| MGMT methylation status | |
| Unmethylated | 12 (40) |
| Methylated | 18 (60) |
| IDH mutation status | |
| Mutated | 12 (40) |
| Wild type | 18 (60) |
| 1p/19q co-deletion status | |
| Co-deleted | 11 (36.7) |
| Non-co-deleted | 19 (63.3) |
HGG high-grade glioma; KPS Karnofsky performance status; IQR interquartile range; PTBE peritumoral brain edema; MGMT O6-methylguanine-DNA-methyltransferase; IDH isocitrate dehydrogenase; 1p/19q co-deletion the co-deletion of chromosome arms 1p and 19q